PerioTrap Pharmaceuticals GmbH

PerioTrap Pharmaceuticals GmbH

Private
Halle (Saale)Healthcare & Life Scienceshttps://periotrap.com

Last Round

VC Round

Feb 6, 2025

Total Funding Raised

$3.54M

Momentum Score

50 /100

Company Overview

PerioTrap Pharmaceuticals GmbH is a life sciences company that develops an innovative anti-infective drug for the curative treatment of periodontitis, an inflammatory gum disease caused by specific bacteria.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B2C

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

pathoblockermicrobiome oral careselective inhibitorperiodontitis treatmentgum disease preventionoral microbiomePorphyromonas gingivalissmall-molecule inhibitorchlorhexidine alternativeprofessional dental geldental biotechveterinary oral care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PerioTrap Pharmaceuticals GmbH Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PerioTrap Pharmaceuticals GmbH Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 6, 2025
SeedOct 21, 2020

Key People

Founding team and executive leadership

Pierre Tangermann

CEO

Executive Team

PerioTrap Pharmaceuticals GmbH Investors

Notable investors and investment history

InvestorRounds
Bmp VenturesVC Round
Fraunhofer VentureSeed, VC Round
i&i PragueSeed, VC Round
CompanistoVC Round

PerioTrap Pharmaceuticals GmbH Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PerioTrap Pharmaceuticals GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PerioTrap Pharmaceuticals GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersHalle (Saale)
Employee Range10
Year Founded2019
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.